Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Huifang Wang, Runhua Zhou, Fushan Xu, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 21
Expanding the horizons of targeted protein degradation: A non-small molecule perspective
Xiaowei Huang, Fengbo Wu, Jing Ye, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2402-2427
Open Access | Times Cited: 16
Degron-Based bioPROTACs for Controlling Signaling in CAR T Cells
Matthew S. Kim, Hersh K. Bhargava, Gavin E. Shavey, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 8, pp. 2313-2327
Open Access | Times Cited: 6
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
An mRNA vaccine encoding proteasome-targeted antigen enhances CD8+ T cell immunity
Ling Jin, Hongwei Chen, Mengwen Huang, et al.
Journal of Controlled Release (2025) Vol. 381, pp. 113578-113578
Closed Access
A Comprehensive Primer and Review of PROTACs and Their In Silico Design
Jacopo Zattoni, Paola Vottero, Gea Carena, et al.
Computer Methods and Programs in Biomedicine (2025) Vol. 264, pp. 108687-108687
Open Access
Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells
Mekedlawit Setegne, Aidan T. Cabral, Anushri Tiwari, et al.
ACS Bio & Med Chem Au (2025) Vol. 5, Iss. 2, pp. 268-282
Open Access
Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections
Riming Huang, Yusi Hu, Yifan Wang, et al.
Angewandte Chemie International Edition (2025)
Closed Access
Targeted Degradation of ZBP1 with Covalent PROTACs for Anti‐Inflammatory Treatment of Infections
Riming Huang, Yusi Hu, Yifan Wang, et al.
Angewandte Chemie (2025)
Closed Access
Drosophila as a Promising In Vivo Research Model for the Application and Development of Targeted Protein Inactivation Technologies
Н. В. Дорогова, С. А. Федорова
Archives of Insect Biochemistry and Physiology (2025) Vol. 118, Iss. 3
Closed Access
Transformative potential of plant-based nanoparticles in cancer diagnosis and treatment: bridging traditional medicine and modern therapy
M Aswini, K. S., E P Liyana, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Degron-based bioPROTACs for controlling signaling in CAR T cells
Matthew S. Kim, Hersh K. Bhargava, Gavin E. Shavey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Targeted Protein Degradation Systems: Controlling Protein Stability Using E3 Ubiquitin Ligases in Eukaryotic Species
Yoshitaka Ogawa, Taisei P. Ueda, Keisuke Obara, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 175-175
Open Access | Times Cited: 2
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer
Nicoletta Cordani, Daniele Nova, Luca Sala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11214-11214
Open Access
Page 1

Scroll to top